Successful treatment of MS with autologous hematopoietic stem cell transplantation was accompanied by depletion of CD8+MAIT cells, whereas regulatory T cells and CD56high natural killer cells were increased in the peripheral blood of MS patients (45). This evidence concerns the gene CD8A and myeloid sarcoma.